K. Afanaseva, O. Pirogova, E. Bakin, A. Smirnova, E. Morozova, Y. Vlasova, I. Barkhatov, Tatiana Gindina, I. Moiseev, S. Bondarenko
{"title":"酪氨酸激酶抑制剂:预防费城染色体阳性急性淋巴细胞白血病成人异体造血干细胞移植后复发","authors":"K. Afanaseva, O. Pirogova, E. Bakin, A. Smirnova, E. Morozova, Y. Vlasova, I. Barkhatov, Tatiana Gindina, I. Moiseev, S. Bondarenko","doi":"10.18620/ctt-1866-8836-2022-11-3-4-45-59","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"362 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Tyrosine kinase inhibitors: relapse prophylaxis after allogeneic hematopoietic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia\",\"authors\":\"K. Afanaseva, O. Pirogova, E. Bakin, A. Smirnova, E. Morozova, Y. Vlasova, I. Barkhatov, Tatiana Gindina, I. Moiseev, S. Bondarenko\",\"doi\":\"10.18620/ctt-1866-8836-2022-11-3-4-45-59\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":39111,\"journal\":{\"name\":\"Cellular Therapy and Transplantation\",\"volume\":\"362 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cellular Therapy and Transplantation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-45-59\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular Therapy and Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-45-59","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Tyrosine kinase inhibitors: relapse prophylaxis after allogeneic hematopoietic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia